Cutis verticis gyrata (CVG) also known by the name paquidermia verticis gyrata, cutis verticis plicata, and “bulldog” scalp syndrome, is a rare benign cutaneous disorder that is characterized by convoluted folds and deep furrows of the scalp that mimic cerebral sulci and gyri. It was initially reported in the medical literature in 1837 by Alibert. In 1907, Unna devised the term 'cutis verticis gyrata' which is the accepted nomenclature ever since. In 1953, Butterworth classified CVG into two forms: primary and secondary. In 1984, the classification system was further broken down into primary essential, primary non-essential, and secondary CVG. Primary non-essential cutis verticis gyrata can be associated with neuro-psychiatric and ophthalmological abnormalities. This form now has the name cutis verticis gyrata-intellectual disability (CVG-ID). Secondary and primary non-essential cutis verticis gyrata have associated abnormalities, while primary essential CVG has no associations.
Cutis verticis gyrata has been given a classification system as CVG is a manifestation of a variety of diverse causes rather than an individual disease entity. An understanding of the etiology of CVG helps classify this disease and is essential in its management. A hormonal cause of cutis verticis gyrata has been postulated due to the male predominance and postpubertal onset of this disorder. However, a study of plasma levels of thyroid hormone, cortisol, sex hormone and prolactin levels in 15 patients with cutis verticis gyrata did not show any abnormal hormone levels. The possible role of genetic transmission of CVG is uncertain.
Cutis verticis gyrata is a rare disorder, predominately seen in men, with a reported prevalence of about 1 in 100000 males and 0.026 in100000 females. Primary CVG usually occurs in postpubertal men before the age of 30 with an increased incidence seen in patients with mental disorders. Secondary CVG, which is slightly more common than primary and can occur at any age with no gender predilection. CVG rarely presents in young children.
The pathogenesis of primary cutis verticis gyrata remains unclear. A hormonal influence has been postulated as this disorder usually manifests in postpubertal men. Secondary cutis verticis gyrata is considered to be a manifestation of a variety of underlying causes and the pathophysiology, in this case, can be correlated to the specific underlying condition.
The histological appearance of primary cutis verticis gyrata can show significant variation from case to case. Histological features range from essentially normal skin architecture to thickened connective tissue with hypertrophy or hyperplasia of adnexal structures with or without an associated increase in collagen fibers and trapping of the apocrine and eccrine glands. The histology of the gyrated skin folds in secondary cutis verticis gyrata is that of the underlying disease process.
Cutis verticis gyrata presents with symmetric, redundant scalp folds that exhibit deep furrows and convolutions. The hypertrophy and folding of the skin produce an appearance mimicking that of cerebral gyri. The multiple-thickened skin folds in primary CVG usually present in a symmetric fashion running anterior to posterior, typically involving the vertex and the occiput. Occasionally primary CVG can be seen running in a horizontal direction and affects the entire scalp. In secondary CVG the redundant skin folds may be more asymmetrical and can even be seen on the forehead. In cutis verticis gyrata secondary to inflammatory and systemic disorders, the folds will typically present in a mild corrugated pattern involving the entire scalp. When CVG arises secondary to a neoplasm, it tends to present in the form a localized area of scalp furrowing, that can then progress to encompass the entire scalp.
Due to the many disorders that can cause secondary cutis verticis gyrata, it is only possible to render the diagnosis of primary CVG after complementary investigations have ruled out local or systemic diseases that are secondarily causing cutis verticis gyrata. Corresponding investigations such as skin biopsies, blood tests, and radiological examination are recommended based on the patient’s clinical presentation to distinguish between primary and secondary forms of CVG.
In secondary cutis verticis gyrata, treating the underlying disorder usually causes regression of CVG; however, sometimes further intervention may be required After secondary involvement has been ruled out, primary CVG is treatable in a variety of ways. Local scalp hygiene is important to avoid secretion accumulation, maceration, unpleasant odor, and also to prevent secondary infections Primary cutis verticis gyrata is a benign cutaneous disorder, but because of the associated psychological and cosmetic concerns, surgical intervention remains the most definitive treatment option as of nowThe type of surgical repair will depend on the size, location of the folds, and the expectation of the patient.
Surgical modalities range from simple excisions to tissue expansion and skin grafts for patients with more extensive scalp involvement. Treatment of larger folds can take place in a staged approach with the use of tissue expansion techniques and local flap reconstruction. Alternatively, the surgeon may choose for partial resection of the most abundant segment of the lesion. Myocutaneous flaps or free flaps, such as the latissimus dorsi muscle have also been suggestions for complete resection of excess skin folds. Smaller localized folds can be excised and closed primarily with care to avoid distortion of the brow, eyelid, and hairline depending on the location of the folds. Studies have shown that partial resection with immediate closure is the safest and most effective procedure to correct CVG Patients can safely undergo further resection after a one-year postoperative period.
The appearance of CVG is quite distinctive and making a clinical diagnosis is usually easy. The challenge is to diagnose underlying or associated conditions accurately. The physician must be aware of the common associations and corresponding differential diagnosis. Cutis verticis gyrata now falls under three categories: primary essential, primary nonessential and secondary. Primary essential CVG has no other associated abnormalities. Primary nonessential CVG is associated with mental retardation, neuropsychiatric disorders, seizures, schizophrenia, cerebral palsy, ophthalmologic abnormalities such as cataracts, strabismus, retinitis pigmentosa, and blindness. The IQ of these patients is rarely over 35 and may present with microcephaly, static encephalopathy, and convulsions.
Secondary cutis verticis gyrata has been reportedly associated with pachydermoperiostosis (idiopathic hypertrophic osteoarthropathy), cerebriform intradermal nevus, acromegaly, and other less frequent cause of CVG such as inflammatory diseases of the scalp, scleromyxedema, leukemia, lymphoma, syphilis, acanthosis nigricans, neurofibromas, nevus lipomatosus, tuberous sclerosis, cylindroma, Ehlers-Danlos syndrome, amyloidosis, diabetes mellitus, cutis laxa, intracerebral aneurysm, cutaneous focal mucinosis and the misuse of anabolic steroids. Chromosomal abnormalities such as Turner syndrome, Klinefelter syndrome, Noonan syndrome, Beare-Stevenson syndrome, and fragile X syndrome also have correlations with CVG.
The patient should be aware of cutis verticis gyrata classifications and most importantly the associations relating to CVG. The benign nature must be made clear to the patient.
Cutis verticis gyrata is essentially a benign process. However, an interprofessional team that involves shared decision making is vital. Handling of primary CVG and its secondary associations involves a multispecialty approach to improve outcomes and decrease morbidity. The work-up should involve dermatologists, pediatricians, internists, primary care providers, nurse practitioners, and geneticists to ensure consideration of all possible underlying conditions. For surgical correction, a combined approach involving dermatologists and plastic surgeons is often necessary. An interdisciplinary team approach including the physician specialties cited along with nursing personnel is a prudent approach to care in this condition, providing the best chance for an optimal outcome. [Level V]
|||Koregol S,Yatagiri RV,Warad SR,Itagi NR, A rare association of scleromyxedema with cutis verticis gyrata. Indian dermatology online journal. 2016 May-Jun; [PubMed PMID: 27294055]|
|||Lamelas AM,Taub PJ,Silver L,Kressel A, Congenital Primary Essential Cutis Verticis Gyrata. Eplasty. 2016; [PubMed PMID: 27141249]|
|||Radwanski HN,Almeida MW,Pitanguy I, Primary essential cutis verticis gyrata--a case report. Journal of plastic, reconstructive [PubMed PMID: 18951076]|
|||Yang JJ,Sano DT,Martins SR,Tebcherani AJ,Sanchez AP, Primary essential cutis verticis gyrata - case report. Anais brasileiros de dermatologia. 2014 Mar-Apr; [PubMed PMID: 24770513]|
|||Ennouhi MA,Guerrouani A,Moussaoui A, Idiopathic Cutis Verticis Gyrata in a Female. Cureus. 2018 Jan 23; [PubMed PMID: 29581917]|
|||Larsen F,Birchall N, Cutis verticis gyrata: three cases with different aetiologies that demonstrate the classification system. The Australasian journal of dermatology. 2007 May; [PubMed PMID: 17535195]|
|||Walia R,Bhansali A, Cutis verticis gyrata. BMJ case reports. 2011 Jun 3; [PubMed PMID: 22693312]|
|||Tucci A,Pezzani L,Scuvera G,Ronzoni L,Scola E,Esposito S,Milani D, Is cutis verticis Gyrata-Intellectual Disability syndrome an underdiagnosed condition? A case report and review of 62 cases. American journal of medical genetics. Part A. 2017 Mar; [PubMed PMID: 28019079]|
|||Mutlu OO,Colak O,Canli M,Akcay A, Scalp Reconstruction With Free Latissimus Dorsi Flap in a Patient With Giant Cutis Verticis Gyrata. The Journal of craniofacial surgery. 2016 Sep; [PubMed PMID: 27536914]|
|||Mukhi SV,Kumar P,Yuvarajkumar D,Raghuveer CV, Eruptive collagenoma. Indian journal of dermatology, venereology and leprology. 2002 Mar-Apr; [PubMed PMID: 17656892]|
|||Ju Q,Song N,Sun J, Eruptive cutaneous collagenoma in a Chinese patient. The Journal of dermatology. 2011 Apr; [PubMed PMID: 21352340]|
|||Lee MW,Choi JH,Sung KJ,Moon KC,Koh JK, A case of eruptive collagenoma. Pediatric dermatology. 2002 Nov-Dec; [PubMed PMID: 12437568]|
|||Kang MH,Kim HJ,Seo YJ,Park EJ,Kim CW,Cho HJ,Kim KH,Kim KJ, A Case of Eruptive Collagenoma on the Left Calf. Annals of dermatology. 2008 Sep; [PubMed PMID: 27303176]|
|||Smith LR,Bernstein BD, Eruptive collagenoma. Archives of dermatology. 1978 Nov; [PubMed PMID: 718226]|
|||Barad P,Fernandes J,Shukla P, Eruptive collagenoma: a rarely reported entity in Indian literature. Indian journal of dermatology. 2015 Jan-Feb; [PubMed PMID: 25657425]|
|||Sharma R,Verma P,Singal A,Sharma S, Eruptive collagenoma. Indian journal of dermatology, venereology and leprology. 2013 Mar-Apr; [PubMed PMID: 23442476]|
|||Dannepond C,Martin L,Kerdraon R,Croué A,Lebidre E,Estève E, [Atypical eruptive collagenoma: two cases]. Annales de dermatologie et de venereologie. 2012 Mar; [PubMed PMID: 22401687]|